BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Business

  Opexa Therapeutics Reports Third Quarter 2013 Financial Results and Provides Corporate Update

  November 8, 2013

   · 

  1 min read
• Business

  InVivo Therapeutics Corporation Reports Third Quarter 2013 Financial Results

  November 8, 2013

   · 

  1 min read
• BioMidwest

  ProNAi Therapeutics, Inc. to Present Phase II Clinical Data at American Society of Hematology for PNT2258, a BCL2 Targeted Drug

  November 8, 2013

   · 

  1 min read
• Biotech Beach

  Santarus Inc. and Pharming Group Announce New Data From Open-Label Repeat Treatment Study With RUCONEST (Recombinant Human C1 Esterase Inhibitor)

  November 8, 2013

   · 

  1 min read
• Pharm Country

  Synergy Pharmaceuticals to Present at 2013 Credit Suisse Healthcare Conference

  November 8, 2013

   · 

  1 min read
• Ontario Institute for Cancer Research Release: Canadian and US Leaders in Cancer Research Announce a Big Data Challenge to Develop Robust Methodologies for Predicting Cancer Mutations

  November 8, 2013

   · 

  1 min read
• Dr. John Wallace, Antibe Therapeutics Inc. Founder and Chief Science Officer, Awarded the Heymans Foundation Memorial Medal

  November 8, 2013

   · 

  1 min read
• Drug Development

  Proteo Inc. / Proteo Biotech AG: Patient Recruitment and Treatment in Elafin CABG Phase II Clinical Trial Completed

  November 8, 2013

   · 

  1 min read
• Drug Development

  R-Tech Ueno Release: Announcement of the Completion of Stage I and the Start of Enrollment for Stage II of the Phase I/II Clinical Trial of Genetically Recombinant Human Serum Albumin (Code: RU-101) Ophthalmic Solution for the Treatment of Severe Dry Eye

  November 8, 2013

   · 

  1 min read
• Aerocrine: British National Institute for Clinical Excellence (NICE) Recommends the Use of FeNO Testing to Help Diagnose and Treat Asthma

  November 8, 2013

   · 

  1 min read